Comprehensive Analyses of Somatic Copy Number Alterations and Mutations Based on the Adenoma–Carcinoma Sequence

IF 3.1 2区 医学 Q2 GENETICS & HEREDITY Genes, Chromosomes & Cancer Pub Date : 2024-09-11 DOI:10.1002/gcc.23267
Tamotsu Sugai, Mitsumasa Osakabe, Noriyuki Uesugi, Wataru Habano, Naoki Yanagawa, Hiromu Suzuki
{"title":"Comprehensive Analyses of Somatic Copy Number Alterations and Mutations Based on the Adenoma–Carcinoma Sequence","authors":"Tamotsu Sugai,&nbsp;Mitsumasa Osakabe,&nbsp;Noriyuki Uesugi,&nbsp;Wataru Habano,&nbsp;Naoki Yanagawa,&nbsp;Hiromu Suzuki","doi":"10.1002/gcc.23267","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aims</h3>\n \n <p>Identifying molecular alterations in the adenoma and carcinoma components within the same tumor would greatly contribute to understanding the neoplastic progression of early colorectal cancer.</p>\n </section>\n \n <section>\n \n <h3> Methods and Results</h3>\n \n <p>We examined somatic copy number alterations (SCNAs) and mutations involved in the adenoma and carcinoma components obtained from the same tumor in 46 cases of microsatellite-stable carcinoma in adenoma, using a genome-wide SNP array and gene mutation panel. In addition, we also performed hierarchical clustering to determine the SCNA frequencies in the tumors, resulting in stratification of the samples into two subgroups according to SCNA frequency. Subgroup 1 was characterized by multiple SCNAs and carcinoma components exclusively, while Subgroup 2 was characterized by a low frequency of SCNAs and both the adenoma and carcinoma components. The numbers of total genes and genes with gains were higher in the carcinoma than adenoma components. The three most frequent gains in both components were located at 1p36.33–1q44, 2p25.3–2q37.3, and 3p26.3–3q29. However, no candidate genes mapped to these regions. <i>APC</i> and <i>KRAS</i> mutations were common in both components, whereas the frequency of <i>TP53</i> mutations was statistically higher in the carcinoma than adenoma component. However, <i>TP53</i> mutations were not correlated with SCNA frequency.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>We suggest that considerable SCNAs and <i>TP53</i> mutations are required for progression from adenoma to carcinoma within the same intramucosal neoplastic lesion.</p>\n </section>\n </div>","PeriodicalId":12700,"journal":{"name":"Genes, Chromosomes & Cancer","volume":"63 9","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gcc.23267","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genes, Chromosomes & Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/gcc.23267","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Aims

Identifying molecular alterations in the adenoma and carcinoma components within the same tumor would greatly contribute to understanding the neoplastic progression of early colorectal cancer.

Methods and Results

We examined somatic copy number alterations (SCNAs) and mutations involved in the adenoma and carcinoma components obtained from the same tumor in 46 cases of microsatellite-stable carcinoma in adenoma, using a genome-wide SNP array and gene mutation panel. In addition, we also performed hierarchical clustering to determine the SCNA frequencies in the tumors, resulting in stratification of the samples into two subgroups according to SCNA frequency. Subgroup 1 was characterized by multiple SCNAs and carcinoma components exclusively, while Subgroup 2 was characterized by a low frequency of SCNAs and both the adenoma and carcinoma components. The numbers of total genes and genes with gains were higher in the carcinoma than adenoma components. The three most frequent gains in both components were located at 1p36.33–1q44, 2p25.3–2q37.3, and 3p26.3–3q29. However, no candidate genes mapped to these regions. APC and KRAS mutations were common in both components, whereas the frequency of TP53 mutations was statistically higher in the carcinoma than adenoma component. However, TP53 mutations were not correlated with SCNA frequency.

Conclusions

We suggest that considerable SCNAs and TP53 mutations are required for progression from adenoma to carcinoma within the same intramucosal neoplastic lesion.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于腺瘤-癌序列的体细胞拷贝数畸变和突变综合分析
目的 识别同一肿瘤中腺瘤和癌成分的分子改变将大大有助于了解早期结直肠癌的肿瘤进展。 方法和结果 我们利用全基因组 SNP 阵列和基因突变面板,对 46 例微卫星稳定的腺瘤癌病例进行了体细胞拷贝数改变(SCNA)和基因突变的检测。此外,我们还进行了分层聚类,以确定肿瘤中的 SCNA 频率,从而根据 SCNA 频率将样本分为两个亚组。亚组 1 的特点是有多个 SCNA,而且只有癌成分;亚组 2 的特点是 SCNA 频率低,而且既有腺瘤成分也有癌成分。癌成分中的总基因数和增益基因数均高于腺瘤成分。这两种成分中最常见的三个增益基因分别位于 1p36.33-1q44、2p25.3-2q37.3 和 3p26.3-3q29。但是,没有候选基因映射到这些区域。APC和KRAS突变在这两种成分中都很常见,而TP53突变的频率在统计学上在癌成分中高于腺瘤成分。然而,TP53 突变与 SCNA 频率无关。 结论 我们认为,在同一粘膜内肿瘤病变中,从腺瘤发展为癌需要相当多的 SCNA 和 TP53 突变。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Genes, Chromosomes & Cancer
Genes, Chromosomes & Cancer 医学-遗传学
CiteScore
7.00
自引率
8.10%
发文量
94
审稿时长
4-8 weeks
期刊介绍: Genes, Chromosomes & Cancer will offer rapid publication of original full-length research articles, perspectives, reviews and letters to the editors on genetic analysis as related to the study of neoplasia. The main scope of the journal is to communicate new insights into the etiology and/or pathogenesis of neoplasia, as well as molecular and cellular findings of relevance for the management of cancer patients. While preference will be given to research utilizing analytical and functional approaches, descriptive studies and case reports will also be welcomed when they offer insights regarding basic biological mechanisms or the clinical management of neoplastic disorders.
期刊最新文献
Epigenetic Modeling of Jumping Translocations of 1q Heterochromatin in Acute Myeloid Leukemia After 5'-Azacytidine Treatment Malignant Bone-Forming Neoplasm With NIPBL::BEND2 Fusion Peter Besmer, PhD Obituary (1940–2024) Aberrant Energy Metabolism in Tumors and Potential Therapeutic Targets Fibromyxoid aSoft Tissue Tumor With PLAG1 Fusion—The First Case in an Adult Patient
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1